Furthermore, EGFR-dependent increase of apoptosis of tumour cells was independent of the sterical configuration of the molecule, i.e., the position of scTRAIL in the IgG molecule, as shown by competition with cetuximab. The gene discussed is EGFR; the disease is neoplasm.